Carolyn Rodriguez
LightNews LightNews
banner
crodriguezmdphd.bsky.social
Carolyn Rodriguez
@crodriguezmdphd.bsky.social
620 followers 400 following 28 posts
Psychiatrist | Neuroscientist | Author | Deputy Editor American Journal of Psychiatry | Deputy Editor Neuropsychopharmacology | AI for Mental Health Initiative | OCD Research | Human Neural Circuitry (HNC) Program
Posts Replies Media Videos
Pinned
crodriguezmdphd.bsky.social
Carolyn Rodriguez @crodriguezmdphd.bsky.social · Sep 2
Thank you @pbs.org Emmy-nominated public TV program "Healthy Minds" for highlighting hoarding disorder on (new) Season 10 Episode 7⭐️Great questions from host & executive producer Dr. Jeff Borenstein; "with help there is hope" @bbrfoundation.bsky.social

www.pbs.org/video/hoardi...
Healthy Minds With Dr. Jeffrey Borenstein | Hoarding Disorder | Season 10 | Episode 7
Cognitive behavior and virtual reality therapies for excessive acquisition, difficulty discarding.
www.pbs.org
crodriguezmdphd.bsky.social
Big thank you to @ksarma.com for an outstanding talk to Stanford AI4MH 👏
November 3, 2025 at 10:15 PM
Reposted by Carolyn Rodriguez
npp-journal.bsky.social
Welcome to new @acnporg.bsky.social Associate Member @drlaramieduncan.bsky.social - we're so happy you're here! #WelcomeToACNP👋
acnporg.bsky.social ACNP @acnporg.bsky.social · Sep 16
Congratulations to Laramie Duncan, Ph.D. a new Associate Member of ACNP! Welcome!! 👋@drlaramieduncan.bsky.social
September 16, 2025 at 4:18 PM
crodriguezmdphd.bsky.social
Congratulations🌟Dr.🌟 Paula Munoz Rodriguez!! Thank you to my wonderful colleague Lea Williams for co-mentoring Paula's neuroscience PhD w/ me & @pineurosci.bsky.social Xue Zhang Appreciate Paula's committee chair @agoldpie.bsky.social members Drs. Knutson, Hosseini, Moya🙌 & Paula’s classmates
September 2, 2025 at 4:57 PM
crodriguezmdphd.bsky.social
Thank you @pbs.org Emmy-nominated public TV program "Healthy Minds" for highlighting hoarding disorder on (new) Season 10 Episode 7⭐️Great questions from host & executive producer Dr. Jeff Borenstein; "with help there is hope" @bbrfoundation.bsky.social

www.pbs.org/video/hoardi...
Healthy Minds With Dr. Jeffrey Borenstein | Hoarding Disorder | Season 10 | Episode 7
Cognitive behavior and virtual reality therapies for excessive acquisition, difficulty discarding.
www.pbs.org
September 2, 2025 at 2:47 PM
Reposted by Carolyn Rodriguez
cdladouceur.bsky.social
Spread the word!! DANS 2025 registration is opening very soon…take a look at some of our amazing speakers! You can present a poster you will present or have presented elsewhere…the goal is to foster discussion. Check dans.pitt.edu for updates!
August 21, 2025 at 7:02 PM
Reposted by Carolyn Rodriguez
mayoonthebrain.bsky.social
Excited to be co-chairing a panel with @argelaguilarvalles.bsky.social featuring
Sophie Holmes, Ellen Bradley, & Craig Ferris for #ACNP2026 in the Bahamas 😎
August 12, 2025 at 6:11 PM
Reposted by Carolyn Rodriguez
umarchatterjee.bsky.social
2) I’m honored to be selected as a mentee for the @acnporg.bsky.social Near-Peer Mentorship Program! 🎉

I’m deeply grateful to everyone in our field who has supported me as a scientist with lived experience! I wouldn’t be here without your belief in me & you challenging the stigma! 🙏🏾 #ACNP2026
August 12, 2025 at 7:58 PM
Reposted by Carolyn Rodriguez
umarchatterjee.bsky.social
THRILLED to share @acnporg.bsky.social news x2!

1) Our study group “Centering Lived Experience in Psychiatric Neuroscience Research” @ericjnestler.bsky.social @mayaschumer.bsky.social @deffinger.bsky.social @viscidula.bsky.social @noelvest.bsky.social @cahill-lab.bsky.social=ACCEPTED! 🤩 #ACNP2026
August 12, 2025 at 7:58 PM
Reposted by Carolyn Rodriguez
wickedneuro.bsky.social
I’m happy to share that I’m starting a new position as Vice Chair of Translational Research in Psychiatry at University of Massachusetts Chan Medical School Department of Psychiatry and Behavioral Sciences!
August 11, 2025 at 5:03 PM
Reposted by Carolyn Rodriguez
nicoleprovenza.bsky.social
I’m very excited to share that I got the NOA for my first R01 to study approach-avoidance behaviors after DBS for OCD! We have an awesome team: Sameer Sheth, Wayne Goodman, Eric Storch, and Ben Hayden at BCM, and Han Yi at JHU APL. 🧠⚡️@bcmocd.bsky.social @bcmhouston.bsky.social @jhuapl.bsky.social
bcmneurosurgery.bsky.social BCM Neurosurgery @bcmneurosurgery.bsky.social · Aug 1
#NEWS: Dr. @nicoleprovenza.bsky.social is the recipient of a new $3.7m R01 award from the #NIH & #NIMH for her project, "Neurophysiological investigation of the approach-avoidance axis in OCD: applications to neuromodulation" 🧠

#DBS #OCD #DeepBrainStimulation #ObsessiveCompulsiveDisorder #Research
Project Title: Neurophysiological investigation of the approach-avoidance axis in OCD: applications to neuromodulation Project Narrative: Despite FDA approval for deep brain stimulation (DBS) for obsessive-compulsive disorder (OCD) in the form of a Humanitarian Device Exemption, this therapy remains underutilized and poorly understood. Based on the pathologically avoidant phenotype underlying OCD and the pro-approach behavior required to overcome fear-based avoidance, we conceptualize our study of the neurophysiological underpinnings of OCD by tracking behavior and ventral striatum neural activity along the approach-avoidance axis. Doing so would create a foundational understanding of the neurobehavioral effects of DBS that will generalize to other disorders characterized by dysregulation of behavior along the approach-avoidance axis. DBS and OCD: Obsessive-compulsive disorder (OCD) has a lifetime prevalence of 2-3% and is a major cause of global disability. OCD is characterized by obsessions (i.e., unwanted intrusive thoughts) and compulsions (i.e., repetitive ritualistic behaviors), and exemplifies a pathologically avoidant phenotype where greater degrees of avoidance are associated with greater symptom severity and treatment resistance. In the 20-40% of OCD patients that are treatment refractory, deep brain stimulation (DBS) of the ventral capsule and ventral striatum (VC/VS) is an effective therapy that achieves significant benefit in 66% of patients. While VC/VS DBS does not acutely relieve OCD symptoms, DBS often produces a “pro-approach” response including an increase in talkativeness, a desire to engage in activities, extroversion, and affiliative behavior. Our central therapeutic hypothesis is that VC/VS DBS achieves eventual benefit in OCD by providing the “boost” in pro-approach behavior that allows individuals to overcome their pathological fear-based avoidance. Thus, we focus on the approach-avoidance axis as one of the critical neurobehavioral axes underlying the pathophysiology of OCD. Our overall goal is to develop a mechanistic understanding of DBS for OCD by rigorously investigating the relationship between clinical symptoms, behaviors (i.e., approachful vs. avoidant), and neurophysiology.
August 1, 2025 at 10:10 PM
Reposted by Carolyn Rodriguez
acnporg.bsky.social
We are delighted to welcome Dr. Kate Fitzgerald
@KDFitzgerald_MD, professor at @columbiapsych.bsky.social and expert in child and adolescent psychiatry, as the newest Associate Editor at NPP! "Meet the Editor" with Dr. Kate Fitzgerald youtu.be/zDnOFSm9kxg?... via
@YouTube @npp-journal.bsky.social
npp's "Meet the Editor" with Dr. Kate Fitzgerald
YouTube video by NPP Journal
youtu.be
July 21, 2025 at 7:33 PM
Reposted by Carolyn Rodriguez
alexkwan.bsky.social
We worked so well as a team for the #GRCPsychedelics @vyazovskiy.bsky.social @viditavaidya.bsky.social @melissaherman.bsky.social

and congrats to @theborislab.bsky.social and @mikaelpalner.bsky.social, who will be the future vice-chairs!
Chairs and vice chairs for the Psychedelics GRC
July 17, 2025 at 1:09 PM
Reposted by Carolyn Rodriguez
alexkwan.bsky.social
Great panel this morning on the human and clinical studies of psychedelics -

my impression is we have come a long way in the last few years in terms of design and quantification #GRCPsychedelics
July 17, 2025 at 4:20 PM
Reposted by Carolyn Rodriguez
daria-ricci.bsky.social
My first time at a GRC had to be #GRCPsychedelics. Drop by my poster today to talk about 5-MeO, Calcium transients and Gamma bands in the anterior insular cortex 🧠🐭
yonicouderc.bsky.social Yoni Couderc @yonicouderc.bsky.social · Jul 15
At #GRCPsychedelics ?
Don’t miss Daria Ricci’s poster (#29) tomorrow and Thursday! She’s a talented PhD student from the Beyeler lab, presenting very cool photometry and in vivo ephys data in the anterior insular cortex, after a single dose of psychedelics 🍄🐭
July 17, 2025 at 4:23 PM
Reposted by Carolyn Rodriguez
nate-h-heller.bsky.social
🌈🧠 The Trip Between Bedside and Bench 🌈🧠
Join us at #SfN2025 for a deep dive into cross-species research in psychedelic neuroscience!

🧬 Posters, 🎤 panels, 🔑 keynotes, 🍸 cocktails, and 🥟 tasty apps await.

RSVP, explore speaker profiles, and help spread the word:
👉 hopkinspsychedelic.org/sfn2025
July 17, 2025 at 2:38 PM
Reposted by Carolyn Rodriguez
melissaherman.bsky.social
#GRCPsychedelics 🔥🔥🔥🔥poster session and our first ever Honorary Best PI poster award to @zenbrainest.bsky.social 🤣🤣🤣
July 15, 2025 at 9:51 PM
Reposted by Carolyn Rodriguez
anna-beyeler.bsky.social
👨‍💻 Open PI position in our institute 👨‍💻 !! If you are an expert in Computational Neuroscience and want to start your lab in Bordeaux, contact us !
www.fens.org/careers/job-...
@neuromagendie.bsky.social
@neurobordeaux.bsky.social
July 10, 2025 at 3:13 PM
Reposted by Carolyn Rodriguez
alexkwan.bsky.social
Good morning! An excellent panel today on the evolving theory for explaining psychedelic drug action #GRCPsychedelics
Morning panel at the GRC meeting.
July 14, 2025 at 4:34 PM
Reposted by Carolyn Rodriguez
stanfordcdh.bsky.social
New research from #StanfordCDH's @jkim-1003.bsky.social & team analyzed 528k patient messages, developing AI to support clinicians with tailored diabetes care. AI is seen as highly useful for education and admin support, but deeper data integration is perceived as risky. go.nature.com/4jKaVKB
April 18, 2025 at 7:06 PM
Reposted by Carolyn Rodriguez
mayoonthebrain.bsky.social
What do we know about the endocannabinoid system in developmental psychopathology?🤔

Find out in our recent paper, led by @pact-lab.bsky.social postdocs @ryanntansey.bsky.social & @marcdferger.bsky.social + collaborator extraordinaire @hmarusak.bsky.social 👇
<em>Journal of Child Psychology and Psychiatry</em> | ACAMH Pediatric Journal | Wiley Online Library
Background The endocannabinoid (eCB) system, the primary target of cannabis, has gained significant attention as a potential novel therapeutic approach for treating a range of psychiatric disorders ...
acamh.onlinelibrary.wiley.com
July 11, 2025 at 12:17 AM
Reposted by Carolyn Rodriguez
theborislab.bsky.social
How much is the psychedelic experience influenced by what we see, hear and read? We made a way to measure it: The Psychedelic Media Exposure Questionnaire - developed by Audrey Evers, Chris Kelly, @shaylalove.bsky.social , @tehseennoorani.bsky.social, validated on >600 respondents. Link below:
The Psychedelic Media Exposure Questionnaire: The development and validation of a new scale assessing psychedelic-related media exposure
Rationale: A reliable and valid instrument is needed to measure exposure to psychedelic-related media to examine the impact of media and expectations on outcomes in psychedelic clinical trials. Object...
www.medrxiv.org
July 9, 2025 at 8:29 PM
crodriguezmdphd.bsky.social
BIG thank you to Russ Altman @rbaltman.bsky.social for having me on to Stanford Engineering's The Future of Everything podcast to talk about Hoarding Disorder.
For those w/ loved ones who struggle w hoarding disorder, there is hope and help, including CBT therapy. @IOCDF #OCDCon
youtu.be/mY97ePrY0M4
The future of hoarding disorder
YouTube video by Stanford University School of Engineering
youtu.be
July 12, 2025 at 6:23 PM
crodriguezmdphd.bsky.social
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
www.sciencedirect.com/science/arti...
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
Obsessive-compulsive disorder (OCD) is a common and disabling condition. A large proportion of patients fail to respond to first-line treatment with s…
www.sciencedirect.com
July 3, 2025 at 6:45 PM
Reposted by Carolyn Rodriguez
alexkwan.bsky.social
Can’t believe #GRCPsychedelics is happening in two weeks!

We reached capacity attendance – sorry we could not accommodate everyone. We look forward to seeing many of you at the meeting.

w/ @vyazovskiy.bsky.social @viditavaidya.bsky.social @melissaherman.bsky.social
GRC Neurobiology of Psychedelics conference (July 13-18, 2025).
June 26, 2025 at 6:34 PM
Reposted by Carolyn Rodriguez
neuroangelica-atb.bsky.social
ACNP registration ✅
ACNP abstract submission ✅
NPP paper published today ✅
Feels like baby steps but they are definitely moving forward 👩🏻‍🔬
acnporg.bsky.social ACNP @acnporg.bsky.social · Jun 23
Submissions are NOW OPEN for poster abstracts for the ACNP 64th Annual Meeting: January 12-15, 2026, Nassau, Bahamas. You must be registered for the meeting before you can submit a poster. Deadline to submit is August 28, 2025, at 5:00 pm Central. https://bit.ly/3TXuYcz #ACNP2026
June 25, 2025 at 10:27 PM